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The triumphant success of RNA interference (RNAi) in life sciences is based on its high potency to silence genes in a sequence-
speciﬁc manner. Nevertheless, the ﬁrst task for successful RNAi approaches is the identiﬁcation of highly active small interfering
RNAs (siRNAs). Early on, it has been found that the potency of siRNAs can vary drastically. Great progress was made when
thermodynamic properties that inﬂuence siRNA activity were discovered. Design algorithms based on these parameters enhance
thechancetogeneratepotentsiRNAs.Still,manysiRNAsdesignedaccordinglyfailtosilencetheirtargetedgene,whereasothersare
highly eﬃcient despite the fact that they do not fulﬁl the recommended criteria. Therefore, the accessibility of the siRNA-binding
site on the target RNA has been investigated as an additional parameter which is important for RNAi-mediated silencing. These
and other factors which are crucial for successful RNAi approaches will be discussed in the present review.
Copyright © 2006 Jens Kurreck. This is an open access article distributed under theCreative Commons AttributionLicense, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
RNA interference (RNAi) is a naturally occurring phenome-
nonofRNA-mediatedgenesilencingthatishighlyconserved
among multicellular organisms (for recent reviews, see, eg,
[1–4]). It is a post-transcriptional process initiated by dou-
ble-stranded RNA molecules that induce degradation of a
complementary target RNA. In the ﬁrst step of the path-
way, long double-stranded RNA molecules are chopped into
shorter duplexes with 2 nucleotide overhangs at both 3  ends
by an endonuclease dubbed Dicer, the structure of which
has been solved only recently [5]. The resulting 21mer eﬀec-
tor RNAs, named small or short interfering RNAs (siRNAs),
are incorporated into a multimeric protein complex, the
RNA-induced silencing complex (RISC). One of the two
siRNA strands guides RISC to a complementary RNA. After
hybridization the endonucleolytic “slicer” activity of RISC
cleaves the target RNA, thus preventing its translation.
While long double-stranded RNA molecules can be em-
ployed to induce RNAi in lower eukaryotes, siRNAs being
21 nucleotides in length have to be used for gene silencing
in mammalian cells in order to prevent the activation of an
unspeciﬁc interferon response [6]. Due to the higher eﬃ-
ciency of siRNAs compared to traditional antisense oligonu-
cleotides and ribozymes [7–9] and the relative ease of RNAi-
mediated knockdown of target gene expression compared to
knockout by homologous recombination, RNAi has rapidly
become a standard technology in life sciences. Furthermore,
siRNAs are not only new powerful researchtools, butare also
considered to be a promising new class of therapeutics [10–
13].
In addition to siRNAs, endogenously expressed short
double-stranded RNA molecules, referred to as microRNAs
(miRNAs), entered the focus of current research (for a re-
view, see [14]). These molecules are now believed to be im-
portant cellular gene regulators that play an important role
in developmental processes and various diseases. At the be-
ginning of the miRNA pathway, RNA polymerase II gener-
ates long primary RNAs that contain the miRNA sequences.
These transcripts designated as pri-miRNAs are cleaved in
the nucleus by an RNase III family enzyme, Drosha, to give
the pre-miRNAs approximately 70–90 nucleotides with a 2
nucleotide 3  overhang. After being exported to the cyto-
plasm, the pre-miRNA is recognized by Dicer and processed
to generate the mature miRNA, which is incorporated into
RISC. In contrast to siRNAs, however, miRNAs are capable
of inhibiting translation of the targeted mRNA without de-
grading it (at least in mammalian cells). Still, the siRNA and
miRNA pathways share many similarities. Elucidation of the
mechanismsofmiRNAactivitythereforehelpstounderstand
the mode of action of siRNAs and vice versa.
Despite the great success of RNAi mediated approaches,
the design of highly eﬃcient siRNAs still remains a hurdle
that has to be overcome. Initial expectations expressed on an
antisense meeting in 2001 that there is no need to select for
optimal siRNA target sequences [15]h a v es o o nb e e np r o v e n
to be too optimistic, since a drastic variation of silencing
eﬃciency was observed for diﬀerent siRNAs directed against2 Journal of Biomedicine and Biotechnology
the same target RNA [16]. It thus became clear that either
factors intrinsic to the siRNA or properties of the targeted
mRNA are crucial for the success of an RNAi approach. In
the present review our current knowledge about factors that
inﬂuence the potency of siRNAs will be summarized and ad-
vice will be given that helps with the generation of eﬃcient
molecules. It will, however, become obvious that we do not
yet know all relevant features so that even the sophisticated
design algorithms available to date do not guarantee satisfac-
tory activity of the proposed siRNAs.
THERMODYNAMIC PROPERTIES OF EFFICIENT siRNAs
Early on, recommendations have been given for the selection
of siRNA target sites [17]: the selected region should prefer-
ably be located in the coding region, at least 50 nucleotides
downstream of the start codon; the GC-content should be
approximately 50%; and a sequence motive AA N19 TT was
suggested to be advantageous. A blast search is necessary to
ensure that the siRNA has no signiﬁcant homologies with
other genes than the intended target. Even though these se-
lection criteria have been employed with great success in nu-
merous RNAi experiments, a further increased hit rate for
highly potent siRNAs was desirable for the generation of
large libraries. Signiﬁcant progress towards the design of ac-
tive siRNAs was achieved when an unexpected asymmetry
concerning the incorporation of the two strands of siRNAs
and miRNAs was found in two independent studies [18, 19].
Analysis of the known miRNA sequences in the context of
miRNA precursor hairpins revealed a low stability of the 5 
end of the antisense strand compared to the 5  end of the
sense strand [18]. Subsequently, the same feature was ob-
served for siRNAs. Functional duplexes displayed a lower
relative thermodynamic stability at the 5  end of the anti-
sense strand than nonfunctional duplexes. The ﬁnding that
the relative stabilities of the base pairs at the termini of the
two siRNA strands that determine the degree to which each
strandisfedintotheRNAipathwayledtothehypothesisthat
strand incorporation into RISC is determined by an RNA
helicase that initiates dissociation of the miRNA or siRNA
duplex at the end with the lower thermodynamic stability
[19].
These ﬁndings were further reﬁned in a systematic anal-
ysis of 180 siRNAs targeting the mRNAs of two genes [20].
In addition to the relative stability of both ends of the siRNA,
base preferences at certain positions of the duplex were iden-
tiﬁed in functional siRNAs. A set of eight criteria was used
in an algorithm intended to improve the selection of po-
tent siRNAs (Table 1 and Figure 1). A total of 6 or more
points according to this scoring system was proposed to sig-
niﬁcantly increase the probability for eﬃcient gene silenc-
ing.
Independent studies analysing the activities of siRNAs
against diﬀerent mRNAs conﬁrmed the basic outcome of
these studies [eg, [21, 22]]. Although some base preferences
at certain positions of the siRNAs were either questioned or
added to the list, the relative thermodynamic stability of the
siRNA termini was veriﬁed to be a major determinant of
Table 1:DesigncriteriaforsiRNAsaccordingtoReynoldsetal[20].
Criterion Score
GC content between 30–52% 1
(in the 19mer siRNA duplex)
A or U at positions 15–19 1 for each
A at position 19 1
A at position 3 1
U at position 10 1
Go rCa tp o s i t i o n1 9 −1
G at position 13 −1
the functionality of siRNAs. Somewhat diﬀerent results were
obtained, when a database was compiled consisting of 398
siRNAs against 92 genes from 30 diﬀerent studies, in order
to overcome a major shortcoming of earlier studies, the low
number of genes being targeted [23]. Bioinformatic analysis
ofthedatasetledtoasetofrules(termed“Stockholmrules”)
that diﬀers from the scoring systems described above.
Various academic groups and commercial vendors devel-
oped a software for designing siRNAs based on the identiﬁed
features of active siRNAs. A list of freely available web tools
is given in Table 2. Some additional prediction servers were
introduced in a special web server issue of Nucleic Acids Re-
search of July 2004.
In a more recent study, a set of approximately 2200
randomly selected siRNAs targeting 24 mRNA species was
used to train a neuronal network to predict the activity of
siRNAs [25]. Statistic analysis of the large data set revealed
some of the criteria discovered previously, but also identi-
ﬁed new motives that are overrepresented in potent siRNAs.
Theapproachtotrainanartiﬁcialneuronalnetworkgoesbe-
yond earlier eﬀorts like the above-mentioned scoring system,
which uses a linear summation of parameters, in that it can
handlecomplexsequencemotifsandsynergisticrelationsbe-
tween two or more parameters. The neuronal network-based
algorithm wasﬁnallyemployed to design alibrary of approx-
imately 50.000 siRNAs that cover the human genome with a
redundancy of two siRNAs per gene.
Takentogether,theanalysisofthesequencesofactiveand
nonfunctional siRNAs clearly revealed that the two strands
of an siRNA duplex are not equally eligible for assembly into
RISC. Rather, the relative stability of both ends of the siRNA
is widely considered to determine which of the strands will
preferentially participate in the RNAi pathway. It is therefore
advisable to take into account the proposed criteria for active
siRNAswhendesigning siRNAsagainstanewtarget.Ithasto
be mentioned, however, that following these algorithms does
not guarantee for the success of an RNAi approach. On the
contrary, numerous highly eﬃc i e n ts i R N A sh a v eb e e np u b -
lished that do not obey the rules. Before addressing further
determinants of siRNA activity in more detail, a short sum-
mary of structural studies will be given that may account for
the asymmetric incorporation of the two siRNA strands into
RISC.Jens Kurreck 3
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Figure 1: Features of eﬃcient siRNAs according to Reynolds et al [20]. The relative stability of both ends of the siRNA as well as the bases in
certain positions inﬂuences the activity of siRNAs (H = A, C or U).
Table 2: Web sites for the design of eﬀective siRNAs (based on [24] with modiﬁcations).
Source URL
Dharmacon www.dharmacon.com/sidesign/
Hannon Lab katahdin.cshl.org:9331/homepage/siRNA/RNAi.cgi?type=siRNA
Integrated DNA Technologies scitools.idtdna.com/RNAi
Sonnhammer Lab sisearch.cgb.ki.se
Invitrogen rnaidesigner.invitrogen.com/sirna
McManus Lab
Qiagen http://www1.qiagen.com/Products/GeneSilencing/CustomSiRna/SiRnaDesigner.aspx
Sfold Algorithm http://sfold.wadsworth.org/index.pl
Whitehead Institute http://Jura.wi.mit.edu/siRNAext
MWG-Biotech http://www.mwg-biotech.com/html/s synthetic acids/s sirna design.shtml
STRUCTURAL BASIS FOR STRAND ASYMMETRY
In recent years, signiﬁcant progress has been made to eluci-
date the molecular basis of RNAi and to understand the
asymmetric strand incorporation (for a review, see [26]).
The catalytic activity of RISC, termed slicer, which leads to
the cleavage of the target RNA, has been identiﬁed to be lo-
cated in the Argonaute2 (Ago2) protein [27]. Ago2 contains
two major domains referred to as PIWI and PAZ (acronym
for PIWI/Argonaute/Zwille). Crystallographic analysis re-
vealed the PIWI domain at the C-terminus of the protein to
closely resemble the structure of RNase H [28]. This enzyme
cleaves the RNA component of an RNA/DNA hybrid. The
P I W Id o m a i no fA g o 2c a nt h u sb er e g a r d e da sav a r i a n to f
the RNase H structure motive specialized in cleavage of one
strand of double-stranded RNAs.
Recombinant human Ago2 and an siRNA were found to
form a minimal RISC that accurately cleaves substrate RNAs
[29]. Interestingly, only single-stranded siRNA could be spe-
ciﬁcally incorporated into recombinant Ago2, whereas pho-
toreactive double-stranded siRNA did not crosslink with
Ago2. This ﬁnding indicates the importance of the RISC
loading complex (RLC) for eﬃcient incorporation of the
siRNA into the Ago2 protein. In Drosophila melanogaster,a
heterodimer consisting of Dicer-2 and the double-stranded
RNA binding protein R2D2, which contains the siRNA, was
found to be important for RISC assembly [30]. R2D2 binds
thethermodynamicallymorestableendofthesiRNA,thatis,
the 3  end of the guide strand, and can thus determine which
one of the strands will be associated with Ago2. It has there-
forebeendescribedasthe“proteinsensorforsiRNAthermo-
dynamic asymmetry.”
In human cells, the HIV-1 trans-activating response
RNA-binding protein (TRBP) has been found to recruit the
Dicer complex to Ago2 [34]. Based on these ﬁndings a model
has been proposed for RISC assembly and function [31] that
is depicted in Figure 2. In cytoplasm, RISC containing Dicer,
TRBP, and Ago2 recognizes hairpin RNAs like pre-miRNAs.
The RNase III Dicer generates ∼22nt long duplexes which
remain associated with RISC as a ribonucleoprotein com-
plex. In analogy to R2D2 from Drosophila,T R B Pa n dD i c e r
are likely to sense the thermodynamic asymmetry between
the two ends of the duplex. Two recent reports suggest that
the passenger strand is cleaved, before being removed from
the Ago2 protein [32, 33]. The guide strand remains bound
to the active RISC and recognizes target RNAs by comple-
mentary base pairing. The PIWI domain of Ago2 cleaves the
target RNA. After release of the cleavage products, RISC can
undergo further rounds of target RNA destruction. Interest-
ingly, none of these steps requires energy from ATP hydrol-
ysis. Although RISC can utilize 21mer siRNA duplexes, pre-
miRNA-typeDicersubstratesresultina10-foldhigheractiv-
ity [31].
TARGET SITE ACCESSIBILITY
Although there is no doubt that the design criteria de-
scribed above increase the success rate to generate active siR-
NAs, a survey of published RNAi experiments readily re-
veals that many siRNAs are highly potent although they do4 Journal of Biomedicine and Biotechnology
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Figure 2: Model for assembly and function of RISC according to
[31] under consideration of [32, 33].
not fulﬁl the recommendations. Even more intriguing is the
fact that siRNAs may be unsuitable to silence their target
although they comply with these rules. It is thus obvious
that additional features have to be considered to optimize
the eﬃciency of RNAi. Some earlier studies had already sug-
gested that the structure of the target RNA may inﬂuence
siRNA activity [35–37]. When it became clear that the de-
sign algorithms based solely on thermodynamic parameters
of the siRNA are helpful tools, but do not guarantee success
of RNAi approaches, target-site accessibility came back into
the focus.
Luo and Chang [38] described the local mRNA struc-
ture at the target site as the main cause for the positional
eﬀect of diﬀerent siRNAs. As a reliable parameter for target
site accessibility, they introduced the “hydrogen bond index”
representing the average number of hydrogen bonds formed
between nucleotides in the target region and the rest of the
mRNA. This index, which has to be determined by bioin-
formatic secondary structure prediction, was found to corre-
late inversely with the gene-silencing eﬀect. Further experi-
mentsrevealedthatthetightstem-loopstructureoftheHIV-
1 transactivation response element (TAR) is detrimental to
silencing by RNAi [39]. In contrast, the location of the
siRNA-binding site within a translated or noncoding region
of the mRNA had only marginal eﬀects.
A systematic global analysis was performed with a set of
siRNAs directed against two target RNAs, for which the ac-
cessibilityofthesiRNAtargetsiteswasdeterminedbyaniter-
ative computational approach and by experimental RNase H
mapping [40]. IC50-values as well as the maximal extent of
target suppression were signiﬁcantly improved for siRNAs
against accessible local target sites compared to those siRNAs
which targeted inaccessible regions of the mRNAs. In con-
trast,therelativethermodynamicstabilityofbothendsofthe
siRNAwasnotfoundtobeasuitablemarkerforsiRNAactiv-
ity. This ﬁnding was further strengthened by a kinetic analy-
sis of isolated human RISC [41]. An siRNA directed against
thehighlystructuredRNAoftheHIV-1TARwasfoundtobe
incapable of target RNA cleavage. When the tight structure
was disrupted by the addition of an oligonucleotide consist-
ing of 2 -O-methyl RNA, target-site accessibility increased
leading to enhanced cleavage of the TAR RNA.
In a recent study, we aimed at deciphering the contri-
butions of both factors, that is, the thermodynamic proper-
ties of the siRNA and the target RNA structure, to the ef-
ﬁciency of an RNAi approach by constructing a set of in-
tentionally designed target sites [42] .Ah i g h l ya c t i v es i R N A ,
which is capable of silencing its full-length target RNA in
the subnanomolar range, maintained its potency when di-
rected against the isolated target site fused to the green ﬂuo-
rescent protein (GFP). Interestingly, a fusion construct with
thesiRNA-bindingsiteinreverseorientationwasfoundtobe
silenced to a much lower extent, conﬁrming the existence of
a strand bias. However, incorporation of the original target
site into a tight hairpin structure was detrimental to silenc-
ing as well. Further experimental and bioinformatic analysis
of a set of target RNAs with varying degrees of target-site ac-
cessibility revealed a linear correlation between the local free
energy in the siRNA-binding region and the extent of gene
knockdown. These ﬁndings demonstrate that the thermody-
namicpropertiesofthesiRNAitselfaswellasthestructureof
the target RNA both inﬂuence the eﬃciency of an siRNA. We
thereforeproposed amodel, accordingto whichtheoutcome
of an RNAi approach is determined at two points of the mul-
tistep process (Figure 3). Firstly, asymmetric strand incorpo-
ration into RISC is controlled by thermodynamic properties
ofthesiRNA;secondly,accessibilityofthetargetsitemayfur-
ther modulate the eﬃciency of silencing. Even siRNAs with
favorable thermodynamic properties may thus be incapable
of inhibiting gene expression in cases in which the binding
region is inaccessible due to tight secondary structures.
Design of siRNAs according to the criteria recommended
byReynoldsetal[20]frequentlyresultsinsatisfactoryinhibi-
tionofgeneexpression.Sometargets,however,arerefractory
to RNAi-mediated silencing, most likely due to the existence
of stable secondary structures. For example, we and others
failed to identify eﬃcient siRNAs against the highly struc-
tured 5  untranslated region of plus-stranded RNA viruses
and were more successful when targeting less tightly ar-
ranged parts of the coding region [43–47]. In some cases, itJens Kurreck 5
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Figure 3: Eﬃciency of an siRNA is determined at two points of the
RNAipathway.(1)Astrandbiasexiststhatisdeﬁnedbytheintrinsic
thermodynamic properties of the siRNA duplex, that is, by the rel-
ative stability of both ends. (2) A highly ordered structure may have
a detrimental inﬂuence on the hybridisation of the siRNA/RISC to
its target site and may therefore reduce the eﬃciency of the silenc-
ing process, even in cases in which the intended antisense strand is
favored for incorporation into RISC. (Reprinted with slight modi-
ﬁcations from the Journal of Molecular Biology; see [42], with kind
permission from Elsevier.)
might be advisable to take the target RNA structure into ac-
count as well. Several freely available design algorithms, for
example, the Sfold web server (http://sfold.wadsworth.org
[48]) and the siRNA design tool oﬀered by MWG-biotech
(http://www.mwg-biotech.com [49]) allow the design of
siRNAs based on thermodynamic properties of the duplexes
with consideration of the predicted secondary structure of
the binding region of a potential siRNA.
STRATEGIES TO IMPROVE siRNA EFFICIENCY
Detailed bioinformatic analysis of the large set of sequence-
activity relationships reported by Huesken et al [25]c o n -
ﬁrmed that the score according to Reynolds et al [20]a s
well as the target-site accessibility correlate with the extent
of siRNA-mediated gene silencing. However, this investiga-
tion clearly revealed that both parameters are insuﬃcient to
fully explain or predict the potency of siRNAs (G. Schramm,
personal communication). Thus, further factors can be ex-
pectedtoinﬂuencethefunctionalityofsiRNAmolecules.Re-
c e n t l y ,P a t z e le ta l[ 50] suggested that the structure of the
guidestrandcouldbeanotherfeature,whichiscrucialforthe
eﬃciency. Employing a series of siRNAs with diﬀerent struc-
tures, guide strands that do not form deﬁned structures or
possess freely available terminal nucleotides, mainly at the 3 
end of the guide strand, were found to increase the eﬃciency
ofsiRNAs(Figure 4).Incontrast,structureswithbase-paired
ends were virtually inactive. Interestingly, in this study nei-
ther the thermodynamic duplex proﬁles nor target mRNA
structure were found to be of major importance for the si-
lencing process.
siRNA
Unwinding
Inactive Active
Figure 4: Inﬂuence of guide RNA structure on siRNA eﬃciency
[50]. siRNA guide strands with base-paired termini were found to
be inactive, whereas guide RNAs with freely accessible ends (mainly
3  ends) were highly eﬃcient.
A strategy to circumvent the need to identify suitable in-
dividual siRNAs is to use mixtures of siRNAs. To this end,
long double-stranded RNA molecules have been processed
in vitro by Escherichia coli RNase III [51]. The resulting
pool of siRNAs, dubbed endoribonuclease-prepared siRNAs
(esiRNA), can subsequently be transfected into cells to si-
lence the corresponding gene. This eﬃcient and cost eﬀec-
tive method allowed the rapid generation of a large library
consisting of more than 5000 esiRNAs [51]. It is still under
debate whether this approach will elicit severe oﬀ-target ef-
fects due to the large number of sequences contained in the
pool. It has, however, also been argued that pooling of siR-
NAs might decrease unspeciﬁc eﬀects, since this strategy di-
lutesouttheoﬀ-targeteﬀectsofeachindividualsiRNA,while
retaining the total target-speciﬁc silencing capacity.
Two independent studies described additional approach-
es to enhance the eﬃciency of a single siRNA. Conventional
siRNAs consist of a 19mer double-stranded region and two
nucleotide overhangs at the 3  ends of each strand. Accord-
ingly, short hairpin RNAs used for vector expression are de-
signed with a 19mer duplex, a loop connecting both strands,
and two to four uridines at the 3  end of the antisense strand.
The two more recent publications now report that longer
siRNA duplexes are up to 100-fold more potent than the cor-
responding conventional 21mer siRNAs [52, 53]. In one of
these studies a set of chemically synthesised siRNAs of vary-
inglengthwasused[52].Theoptimumofsilencingeﬃciency
was found for siRNAs being 27 nucleotides in length. These
27mers were even suitable to target sites that are refractory
to silencing by 21mer siRNAs. Importantly, the 27mer du-
plexes did not activate the interferon response or protein ki-
nase R. The authors of the second publication found 29mer
short hairpin RNAs to be particularly potent inducers of
RNAi [53]. The higher eﬃciency of longer double-stranded
RNA duplexes might be due to the fact that these siRNAs
and shRNAs, respectively, are initially processed by Dicer to
give 21mers. As described above, mechanistic models based
on copuriﬁcation experiments [31] indicate that Dicer is in-
volved in the loading process of siRNAs into RISC, thus ex-
plaining the improved potency of Dicer substrates compared
to traditional 21mer siRNAs. In a follow-up study, 27mer6 Journal of Biomedicine and Biotechnology
duplexes with 2-base 3 -overhangs were found to be superior
compared to blunt-end duplexes [54]. Interestingly, asym-
metric strand utilization was found with the strand carry-
ing the overhang being preferred for silencing. The authors
conclude that Dicer processing confers functional polarity
within the RNAi pathway for longer double-stranded RNAs.
Recently developed strategies to generate siRNAs from a
miRNA environment went along the same lines to employ
Dicer substrates for silencing. Stegmeier et al [55] generated
an siRNA by replacing a naturally occurring miRNA by a
target-speciﬁc siRNA sequence ﬂanked by ∼125 bases of 5 
and3  sequencederivedfromtheprimarymiRNAtranscript.
This construct can be expressed from both Pol III and Pol II
promotors, thus opening the road to use tissue-speciﬁc pro-
motors. The microRNA-type expression of shRNAs has been
found to be superior compared to conventionally expressed
isolated shRNAs and has been used to generate large libraries
covering a substantial fraction of the predicted genes in the
human and mouse genomes [56].
SUMMARY
Various factors have been identiﬁed that contribute to the
eﬃcacy of small interfering RNAs. Thermodynamic proper-
ties of a given siRNA itself inﬂuence its asymmetric incor-
poration into the RNA-induced silencing complex. Further-
more, the local structure of the targeted RNA might render
the siRNA-binding region inaccessible, thus preventing eﬃ-
cient silencing. Additional factors like the availability of free
ends of the siRNA antisense strand have been described to be
relevanttotheinductionofRNAi.Itis,however,clearthatall
of these features still do not provide an exhaustive descrip-
tion of the determinants of siRNA potency. We can therefore
expect additional factors to be identiﬁed that contribute to
the activity of siRNAs. Additional research is needed to fur-
ther increase the success rate when designing siRNAs against
a new target RNA.
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